000 01460 a2200445 4500
005 20250514000056.0
264 0 _c20010712
008 200107s 0 0 eng d
022 _a0378-5173
024 7 _a10.1016/s0378-5173(01)00631-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, M K
245 0 0 _aFormulation of a reservoir-type testosterone transdermal delivery system.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cMay 2001
300 _a51-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAnimals
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDrug Delivery Systems
650 0 4 _aExcipients
650 0 4 _aGels
650 0 4 _aIn Vitro Techniques
650 0 4 _aLactose
_xanalogs & derivatives
650 0 4 _aMale
650 0 4 _aMethylcellulose
_xanalogs & derivatives
650 0 4 _aOxazines
650 0 4 _aRadioimmunoassay
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSkin Absorption
650 0 4 _aSolubility
650 0 4 _aTestosterone
_xadministration & dosage
650 0 4 _aViscosity
700 1 _aZhao, H
700 1 _aLee, C H
700 1 _aKim, D D
773 0 _tInternational journal of pharmaceutics
_gvol. 219
_gno. 1-2
_gp. 51-9
856 4 0 _uhttps://doi.org/10.1016/s0378-5173(01)00631-7
_zAvailable from publisher's website
999 _c11270226
_d11270226